Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06537999 · ClinicalTrials.gov registry record · Phase 2
A Clinical Study to Evaluate DNTH103 in Adults With Multifocal Motor Neuropathy
A Phase 2 study of Multifocal Motor Neuropathy, sponsored by Dianthus Therapeutics.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 36
- Enrollment target
- 20
- Study locations
NCT06537999 is a Phase 2 study of Multifocal Motor Neuropathy that is actively recruiting participants, run by Dianthus Therapeutics. The registered enrollment target is 36 participants. The trial reports 20 study locations across 9 states.
The verdict
NCT06537999, a Phase 2 study of Multifocal Motor Neuropathy, is actively recruiting participants, sponsored by Dianthus Therapeutics.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 36 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this Phase 2 study is to evaluate the safety, tolerability, pharmacometrics, and efficacy of DNTH103 in participants with multifocal motor neuropathy (MMN).
Conditions Studied
Interventions
- DRUG Placebo
- DRUG DNTH103
Study Locations (20)
Other
- Clinical Study Site - Aarhus
- Clinical Study Site - Copenhagen
- Clinical Study Site - Marseille
- Clinical Study Site - Paris
- Clinical Study Site - Rome
- Clinical Study Site - Amsterdam
- Clinical Study Site - Utrecht
- Clinical Study Site - Skopje
- Clinical Study Site - Bydgoszcz
- Clinical Study Site - Katowice
Florida
- Clinical Study Site - Bradenton
- Clinical Study Site - Tampa
Ohio
- Clinical Study Site - Cincinnati
- Clinical Study Site - Columbus
Arizona
- Clinical Study Site - Scottsdale
California
- Clinical Study Site - Los Angeles
Hawaii
- Clinical Study Site - Honolulu
Kansas
- Clinical Study Site - Kansas City
North Carolina
- Clinical Study Site - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2024-09-17 |
| Est. Completion | 2028-03-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06537999
The ClinicalTrials.gov registry entry for NCT06537999 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dianthus Therapeutics, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Multifocal Motor Neuropathy appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT06537999 reports 20 study locations spanning 9 distinct geographic areas - top geographies include Other, Florida, Ohio.
Frequently Asked Questions
What is clinical trial NCT06537999 about?
NCT06537999 is a clinical study titled "A Clinical Study to Evaluate DNTH103 in Adults With Multifocal Motor Neuropathy". The purpose of this Phase 2 study is to evaluate the safety, tolerability, pharmacometrics, and efficacy of DNTH103 in participants with multifocal motor neuropathy (MMN).
What is the current status of trial NCT06537999?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 36 participants. The study started on 2024-09-17. Estimated completion is 2028-03-31.
What conditions does trial NCT06537999 study?
This clinical trial studies the following conditions: Multifocal Motor Neuropathy.
What interventions are being tested in trial NCT06537999?
The interventions under investigation include: Placebo (DRUG), DNTH103 (DRUG).
Who is sponsoring clinical trial NCT06537999?
This trial is sponsored by Dianthus Therapeutics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06537999 being conducted?
This trial has 20 study locations across Arizona, California, Florida, Hawaii, Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multifocal Motor Neuropathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.